NOVIELLO, DANIELE
NOVIELLO, DANIELE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The assessment of multidimensional clinical, biological and patient-reported outcomes to evaluate the efficacy of add-on Lactobacillus rhamnosus GG supplementation in mild ulcerative colitis: a randomized pilot trial
2026 P. Maragno, C. Amoroso, S. Conforti, M. Michelon, I. Honcharyuk, C. Ciafardini, D. Noviello, F. Strati, F. Caprioli, F. Facciotti, M. Vecchi
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis
2026 G. Privitera, C. Bezzio, G. Figlioli, F. D'Amico, J. Mendes, S. Varca, F. Zingone, I.R. Lago, S. Onali, F.A. Caprioli, M. Chaparro, M.B. Acosta, K. Karmiris, N.T. Degabli, L. Dar, L. Pastorelli, A. Gutiérrez, A. Orlando, Y. Zabana, S. Saibeni, D. Piovani, E.V. Savarino, D. Pugliese, F. Magro, S. Danese, A. Armuzzi, S. Bonovas, F. Fanizzi, P. Ferraz, F. Scaldaferri, B. Barberio, I. Moraleja, A. Favale, D. Noviello, J.P. Gisbert, M. Porto-Silva, A. Psistakis, H. Yanai, U. Kopylov, M. Di Pietro, L. Madero-Velázquez, F.S. Macaluso, R. Orlando, R. Gabbiadini, A.D. Buono, L. Loy, G. Migliorisi, C. Zoratti
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study
2026 G. Privitera, F. Palumbo, F.S. Macaluso, L. Laterza, V. Pardi, A. Viola, D. Noviello, B. Barberio, C. Ricci, P. Balestrieri, M. Cappello, G. Maconi, R. Sablich, A. Variola, R. Bennato, L. Pastorelli, L. Grossi, D.G. Ribaldone, A. Buda, F. Bossa, A. Di Sario, A. Viscido, B. Neri, G. Mocci, C. Pagnini, M.B. Principi, M. Coletta, C. Petruzzellis, S. Mazzuoli, S. Festa, A. Mirarnda, C. Bezzio, L. Fanigliulo, G. Rocco, E.D. Pont, R. Spagnuolo, E.V. Savarino, F.A. Caprioli, W. Fries, L. Ceccarelli, F. Scaldaferri, A. Orlando, A. Testa, D. Pugliese, A. Armuzzi
Pro-inflammatory intestinal Th17-cells are tissue-resident, accumulate in the epithelia in Crohn's disease, and predict unresponsiveness to vedolizumab
2026 M. Paroni, C. Faggiano, C. Righetti, I. Dusetti, V. Ranzani, G. Moschetti, D. Noviello, C. Vasco, M. Vecchi, P. Landini, F. Facciotti, S. Abrignani, F. Caprioli, J. Geginat
The long game in ulcerative colitis: mirikizumab's four-year outcomes
2026 D. Noviello, F. Caprioli
VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial
2026 N. Borruel Sainz, X. Serra-Ruiz, F. Guarner Aguilar, F. Castiglione, O. Maria Nardone, L. Laterza, F. Cascella, A. Gasbarrini, A. Dobrowolska, A. Kanikowska, P. Miheller, O. Menyhárt, D. Noviello, F. Caprioli
VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial
2026 C. Amoroso, B. Marinoni, P. Maragno, A. Rimondi, F. Bottaro, C. Ciafardini, M. Muià, I. Honcharyuk, D. Noviello, B. Caridi, E.M. Sommella, A. Bandera, A. Gori, M. Mantero, F. Blasi, R. Ferrucci, A. Priori, F. Strati, M. Vecchi, F. Facciotti, F. Caprioli
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class
2025 T. Innocenti, J. Hanžel, M. Truyens, M. Lukaš, H. Gordon, A. Cremer, T. Molnár, M. Julsgaard, S. Onali, A. Todeschini, O.M. Nardone, N.M. Noor, F. Caprioli, F. Scaldaferri, K. Argyriou, E.V. Savarino, M. Brinar, C.R.H. Hedin, M. Vela González, A. Armuzzi, A. Blesl, A. Aratari, A. Quadarella, T.L. Parigi, L. Bertani, C. Ferracane, M. Uzzan, G. Michalopoulos, A. De Bernardi, K. Katsanos, P. Balestrieri, G. Piñero, K. Karmiris, A.G. Casbas, S. Nikolic, C. Felice, D. Pugliese, P. Pastras, G. Mocci, L. Pouillon, G.J. Mantzaris, L. Ramos, M.J. Casanova, I.E. Koutroubakis, M.J. García, N. Null, L. Bonacci, E. Bonazzi, P. Bossuyt, C. Bezzio, C.C. De Castro Gonçalves, M. Chaparro, T. Christos, A. Curto, S. Danese, B. Farkas, A. Favale, S. Festa, K. Foteinogiannopoulou, F. Fousekis, A. Kapsoritakis, Ž. Krznarić, L. Laterza, C. Liefferinckx, M. Mañosa, D. Noviello, L. Parisio, S. Saibeni, M.T. Sharip, E. Tettoni, T. Lobaton, G. Dragoni
Curing inflammatory bowel diseases: breaking the barriers of current therapies- emerging strategies for a definitive treatment
2025 D. Noviello, C. Amoroso, M. Vecchi, F. Facciotti, F. Caprioli
Editorial: Targeting Urgency in IBD—A Historical Divide
2025 D. Noviello, R. Atreya
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)
2025 D. Noviello, W. Fries, A. Orlando, F.S. Conforti, C. Bezzio, F. Castiglione, M.C. Fantini, E.V. Savarino, S. Festa, D.G. Ribaldone, G. Mocci, L. Grossi, C. Viganò, N. Imperatore, L. Ceccarelli, A.M. Carvalhas Gabrielli, G. Scardino, S. Saibeni, P. Balestrieri, M. Principi, M. Campigotto, A.G. Gravina, R. Spagnuolo, F. Scaldaferri, B. Neri, A. Di Sario, M. Baldoni, R. Di Mitri, E. Tettoni, S. Calderone, A. Armuzzi, F.S. Macaluso, M. Vecchi, M. Ventimiglia, F. Caprioli, C. De Francesco, N. Piazza O Sed, G. Marcozzi, A.D. Guarino, S. Onali, C. De Barba, G. Orrù, A. Laffusa
Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBD
2025 T. Orlemann, D. Zimmermann, H. Hübner, R. Atreya, J. Bodenschatz, D. Noviello, F. Vitali, D. Strobel, R. Janka, W. Uter, A. Hartmann, M. Neurath, T. Rath
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations
2025 N.M. Noor, M. Daperno, J. De Laffolie, A. Mookhoek, P. Sinonquel, U. Kopylov, B. Verstockt, A. El-Hussuna, K. Sahnan, M. Allocca, P. Bossuyt, D. Carter, A. Ensari, M. Iacucci, U.M. Marigorta, D. Noviello, G. Pellino, A. Soriano, I. Cleynen, T. Raine, S. Sebastian, D.C. Baumgart
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
2025 U. Kopylov, B. Verstockt, U. Marigorta, D. Noviello, P. Bossuyt, A. Mookhoek, P. Sinonquel, A. El-Hussuna, K. Sahnan, D. Baumgart, N. M Noor, M. Allocca, D. Carter, A. Ensari, M. Iacucci, G. Pellino, A. Soriano, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics
2025 A. Mookhoek, P. Sinonque, M. Allocca, D. Carter, A. Ensari, M. Iacucci, U. Kopylov, B. Verstockt, D.C. Baumgart, N.M. Noor, A. El-Hussuna, K. Sahnan, U.M. Marigorta, D. Noviello, P. Bossuyt, G. Pellino, A. Soriano, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations
2025 A. El-Hussuna, G. Pellino, A. Soriano, K. Sahnan, A. Mookhoek, P. Sinonque, M. Allocca, D. Carter, A. Ensari, M. Iacucci, U. Kopylov, B. Verstockt, D.C. Baumgart, N.M. Noor, U.M. Marigorta, D. Noviello, P. Bossuyt, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study
2025 D. Noviello, M. Chaparro, C. Viganò, A. Blesl, B. Barberio, H. Yanai, A. Orlando, R. Ferreiro-Iglesias, C. Bezzio, A. Zilli, T. Molnár, C. Gheorghe, F. Conforti, T. Innocenti, S. Saibeni, P. Bossuyt, R. Oliveira, A.M. Carvalhas Gabrielli, A. Losco, S. Vieujean, E. Tettoni, L. Pirola, S. Calderone, M. Kornowski Cohen, G. Dragoni, T. Rath, M. Barreiro-de Acosta, E.V. Savarino, J.P. Gisbert, M. Vecchi, R. Atreya, F. Caprioli
Resolving loss of response to ustekinumab in Crohn’s disease: POWER through or switch treatment?
2025 D. Noviello, R. Atreya, N.M. Noor
AIEC-dependent pTh17 cells generation relies on distinct virulence-determinants implicated in persistence and inflammatory response of intestinal epithelial cells and macrophages
2024 I. Dusetti, D. Noviello, D. Dolfini, N. Barnich, E. Billard, C. Consolandi, F. Facciotti, F. Caprioli, M. Paroni
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
2024 M. Allocca, G. Catalano, E.V. Savarino, M. Chaparro, A. Levartovsky, G. Michalopoulos, N. Viazis, F.S. Fousekis, A. Psistakis, D. Noviello, C.N.D. Nascimento, B. Caron, V. Kitsou, G. Bamias, M.J. García, E. Zacharopoulou, K. Foteinogiannopoulou, F. D'Amico, I. Koutroubakis, P. Ellul, M. Tzouvala, L. Peyrin-Biroulet, J. Torres, F. Caprioli, K. Karmiris, A. Theodoropoulou, K.H. Katsanos, D.K. Christodoulou, G.J. Mantzaris, U. Kopylov, J.P. Gisbert, S. Danese, F. Magro, F. Carla, G. Fiorino